Additional radiotherapy to breast‐conserving surgery is an optional treatment for de novo stage IV breast cancer: A population‐based analysis

医学 乳腺癌 保乳手术 放射治疗 内科学 倾向得分匹配 乳房切除术 肿瘤科 人口 流行病学 比例危险模型 队列 妇科 阶段(地层学) 胃肠病学 癌症 生物 古生物学 环境卫生
作者
Jun Wang,Shi‐Ping Yang,Ping Zhou,Chen‐Lu Lian,Jian Lei,Hua Li,Zhen‐Yu He,San‐Gang Wu
出处
期刊:Cancer Medicine [Wiley]
卷期号:10 (5): 1634-1643 被引量:12
标识
DOI:10.1002/cam4.3751
摘要

BACKGROUND: We aim to assess the value of locoregional treatment (LRT) including breast-conserving surgery (BCS), mastectomy (MAST), and radiotherapy (RT) in patients with de novo stage IV breast cancer. METHODS: Patients with de novo stage IV breast cancer were retrospectively identified from the Surveillance, Epidemiology, and End Results database between 2004 and 2014. Kaplan-Meier analysis, log-rank tests, propensity score matching (PSM), and the multivariate Cox proportional model were used for statistical analysis. RESULTS: A total of 5798 patients were identified including 849 (14.6%), 763 (13.2%), 2338 (40.3%), and 1848 (31.9%) who received BCS alone, BCS+RT, MAST alone, and MAST+RT, respectively. The proportions of receiving BCS decreased from 35.9% in 2004 to 26.2% in 2014 (p = 0.002), and the probability of patients receiving MAST increased from 64.1% in 2004 to 74.8% in 2014 (p = 0.002). Before PSM, there was a significant difference in breast cancer-specific survival (BCSS) among the treatment arms. Patients who received RT had better BCSS, the 5-year BCSS was 40.5%, 52.3%, 41.5%, and 47.7% in patients treated with BCS alone, BCS+RT, MAST alone, and MAST+RT, respectively (p < 0.001). In the PSM cohort, patients treated with BCS alone had lower 5-year BCSS compared to those treated with BCS+RT (43.9% and 52.1%, p = 0.002). However, there were comparable 5-year BCSS between BCS+RT and MAST alone groups (51.3% and 50.1%, p = 0.872), and BCS+RT and MAST+RT cohorts (51.5% and 55.7%, p = 0.333). Similar results were confirmed in multivariate analysis. CONCLUSIONS: Postoperative RT improves BCSS in patients with de novo stage IV breast cancer, and BCS+RT shows a non-inferior outcome compared to MAST+RT. BCS+RT may be the optimal local management of de novo stage IV breast cancer.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
MAX完成签到,获得积分20
刚刚
1秒前
搜集达人的应助被隔壁小王采纳,获得10
2秒前
3秒前
3921337477发布了新的文献求助10
3秒前
李爱国的应助被Wyf采纳,获得10
4秒前
wuli发布了新的文献求助10
4秒前
慕青的应助被zhang采纳,获得10
4秒前
klee完成签到,获得积分10
4秒前
LLW发布了新的文献求助10
4秒前
Lorry完成签到,获得积分10
5秒前
5秒前
YingxueRen完成签到,获得积分10
6秒前
MAX发布了新的文献求助30
6秒前
6秒前
6秒前
丑角苏发布了新的文献求助20
7秒前
所所的应助被小生不才采纳,获得10
8秒前
wyd完成签到,获得积分10
9秒前
思源的应助被倔强的研究生采纳,获得10
9秒前
小白虫完成签到,获得积分10
10秒前
Lucas的应助被456qwe采纳,获得10
11秒前
promise完成签到 ,获得积分10
11秒前
EstAffectus发布了新的文献求助30
12秒前
12秒前
13秒前
万能图书馆的应助被Linzi采纳,获得10
13秒前
Hoshieko完成签到,获得积分10
13秒前
wuli完成签到,获得积分10
14秒前
14秒前
朴BOSS完成签到,获得积分10
15秒前
香蕉觅云的应助被Yy采纳,获得10
15秒前
15秒前
Gjorv完成签到 ,获得积分10
16秒前
wanci的应助被Lu采纳,获得10
16秒前
16秒前
皮鞋小蛋糕完成签到,获得积分10
16秒前
17秒前
123发布了新的文献求助30
18秒前
zhang发布了新的文献求助10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184508
求助须知:如何正确求助?哪些是违规求助? 9573479
关于积分的说明 21831986
捐赠科研通 7781752
什么是DOI,文献DOI怎么找? 3434372
关于科研通互助平台的介绍 2558482
邀请新用户注册赠送积分活动 2480962